Latest ImaginAb Inc. Stories
SAN ANTONIO, June 7, 2011 /PRNewswire/ -- ImaginAb, Inc. is pleased to announce the availability of custom radiolabeling services for proteins, peptides and other macromolecules as of the 1st of July 2011.
OXFORD, United Kingdom, June 6, 2011 /PRNewswire/ -- Oxford BioMedicaplc ("Oxford BioMedica" or "the Company") (LSE: OXB), a leading gene therapy company, today announces that it has signed a research collaboration agreement with ImaginAb, Inc.
LOS ANGELES, June 6, 2011 /PRNewswire/ -- ImaginAb, Inc. has been invited to join KeyMarker, a leading consortium of Belgian academic scientists and biotech companies for the discovery of new diagnostic and therapeutic targets for diabetes.
- The parings of haberdine; also, any kind of fragments.